SOVREMENNAYA PEDIATRIYA.2016.7(79):42-46; doi 10.15574/SP.2016.79.42 

Efficiency of Traumeel S in treatment of acute bronchitis in children 

Smeyan A. I., Moschich A. P., Bynda Т. P., Dychko M. M.

Sumy State University, Ukraine

Shupyk National Medical Academy of Postgraduate Education, Ukraine 

The aim of this study is improvement of the treatment of children with acute bronchitis using complex bio-regulatory drug Traumeel S on background of standard therapy.

Materials and methods. 50 patients diagnosed with acute bronchitis aged 7 to 18 years were divided into two equal groups of 25 children. In the study group patients received, in addition to standard therapy, the drug Traumeel S, intramuscular injections, age-specific dose 1 time per day during 7 days, daily, followed by another 3 injections once per two days. The children of comparition group received standard therapy. To assess the dynamics of inflammation and organism reactivity were used proteinogram, shift of leucocytes index (SLI) and lymphocytic index (LI).

Results. In the group which received Traumeel S SLI and LI significantly changed towards normal rates at the 7th day, while in the comparison group significant changes were recorded only after 14 days of treatment. The levels of α-2 globulin was significantly different (r<0.05) on the 1st and the 14th day of hospitalization only in children who received additional treatment with Traumeel S, which can serve as a sign of faster dynamics of inflammation completion.

Conclusions. The inclusion of the drug Traumeel S in the treatment regimen of acute bronchitis in children promotes more rapid restoration of normal immune reactivity and inflammation completion.

Key words: acute bronchitis, Traumeel S, bio-regulatory therapy, complex bio-regulatory drug.

REFERENCES

1. Babushkina AV. 2010. Ostryiy bronhit: sovremennyie predstavleniya. UkraYinskiy medichniy chasopis. 6(80): 70—75.

2. Yermakova OV. 2010. Khronichni obstruktyvni zakhvoriuvannia lehen u profesiinii patolohii. Ukrainskyi zhurnal z problem medytsyny pratsi. 1(21): 61—73.

3. Katerenchuk IP, Popovich SV. 2016. Traumel S — bioregulyatsionnyiy podhod v terapii vospaleniya. Novosti meditsinyi i farmatsii. 1(561): 8—9.

4. Kliniko-Informatsionnyiy otdel: Obraz Traumel S, kak universalnogo protivovospalitelnogo preparata. Biologicheskaya Terapiya. 2006. 1: 22—23.

5. Kostromina VP, Yaroschuk LB. 2006. Zabolevaniya organov dyihaniya: vzglyad na problemu s tochki zreniya gomotoksikologii i vozmozhnosti antigomotoksicheskoy terapii v lechenii zabolevaniy dyihatelnoy sistemyi. Ukrainskyi pulmonolohichnyi zhurnal. 2: 21—23.

6. Martyinchuk AA, Popovich SV. 2016. Traumel S — bioregulyatsionnyiy podhod pri travmah i vospalenii. Travma. 2: 13—17.

7. Marushko YuV, Moskovenko ED, Bryuzgina T S. 2013. Efficiency of primrose syrup phytopreparation in the treatment of acute bronchitis in children. Sovremennaya pediatriya. 5(53): 80—84.

8. Marushko YuV, Hyshchak TV. 2014. Tsefpodoksymu proksetyl u likuvanni hostrykh bronkhitiv bakterialnoi etiolohii v ditei. Zdorove rebenka. 5(56): 29—33.

9. Ostapenko O. 2016. Bioregulatory opportunities of Viburkol and Limphomiozot medicines in obstetries and gynecology. Health of woman. 2(108): 49—52.

10. Popovich SV. 2015. Limfomiozot — bioregulyatsionnyiy podhod v terapii detskih zabolevaniy. Zdorove rebenka. 7(67): 64—68.

11. Sakovich AR. 2012. Gematologicheskie leykotsitarnyie indeksyi pri ostrom gnoynom sinusite. Meditsinskiy zhurnal. 4(42): 88—91.

12. Smiian OI, Hrynyshyn VV. 2008. Hostryi bronkhit u strukturi zakhvoriuvan dykhalnoi systemy u ditei rannoho viku ta deiaki aspekty ratsionalnoi antybakterialnoi terapii. Visnyk SumDU. 2: 104—109.

13. Speranskiy II, Samoylenko GE, Lobacheva MV. 2009. Obschiy analiz krovi — vse li ego vozmozhnosti ischerpanyi? Integralnyie indeksyi intoksikatsii kak kriterii otsenki tyazhesti techeniya endogennoy intoksikatsii, ee oslozhneniy i effektivnosti provodimogo lecheniya. Ostryie i neotlozhnyie sostoyaniya v praktike vracha. 6(19): 51—57.

14. Strelnikova OA, Parshina SS. 2013. Opyit parenteralnogo primeneniya preparata «Traumel S» pri ORZ, oslozhnivshemsya ostryim gnoynyim bronhitom. Byulleten meditsinskih Internet-konferentsiy. 3; 1: 21—22.

15. Strizh VO, Kostromina VP. 2010.Acute bronchitis at children: modern aspects of anti-inflammatory therapy. Sovremennaya pediatriya. 1(29): 99—104.

16. Hayne H. 2004. Znachenie antigomotoksicheskoy terapii v regulyatornoy meditsine. Biologicheskaya Meditsina. 2: 4–9.

17. Shamugiya BK, Timoshkov MV. 2013. Vozmozhnosti preparata Traumel S. Mistetstvo lIkuvannya. 2—3(98—99): 44—49.

18. Shamugiya BK, Klimenko VG. 2012. Osnovyi patogeneticheskoy bioregulyatsionnoy terapii. Bioregulyatsionnaya terapiya. 12(75): 72—74.

19. Yudina LV. 2014. Ostryiy bronhit — lechit ili ne lechit. Semeynaya meditsina. 4(54): 63—66.